TerminatedEUCTR 2017-000368-14
A head-to-head randomized clinical trial of methylphenidate and lisdexamphetamine treatment for executive functions and global functioning in adults with ADHD
This historical record does not confirm current site availability.
Historical research recordSweden
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who could participate?
This study is for people with ADHD. Other eligibility criteria apply.
- Listed locations
- Sweden
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Terminated
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Sahlgrenska Univerisity Hospital Gothenburg
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Sweden
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2017-000368-14
- Official title
Show the full official title
A head-to-head randomized clinical trial of methylphenidate and lisdexamphetamine treatment for executive functions and global functioning in adults with ADHD
Recruitment & locations
TerminatedSweden
Registry details
Historical country statuses
- Sweden — Prematurely Ended
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Sahlgrenska Univerisity Hospital Gothenburg, a hospital or academic medical center.
Who can participate?
This study is for people with ADHD. Other eligibility criteria apply.
Is this study still recruiting?
The historical registry lists this study as terminated.
Want to find a study that may fit you better?
Explore HopeStage studies by mental health topic and refine the results to suit your situation.
Find a study that may fit meRelated studies
A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents
Extended-release injectable suspension naltrexone (XR-NTX) as an adjunt pharmacotherapy for prevention of substance use in patients with SUD who are currently in treatment for ADHD: A multicenter r...
